Clinical Trial Update: Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements [Phase 2]

View source ↗

Summary

Phase 2 double-blinded trial of Apatone for symptomatic issues after total joint replacement has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edematous
• Foreign-body Reaction
• Osteolysis
• Synovitis

Drugs mentioned

• Apatone®

Snippet

Sponsor: IC-MedTech Corporation | Conditions: Edematous, Synovitis | Phase 2 | Status: COMPLETED | Results posted: 2018-01-31